|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 62.10 USD | -0.11% |
|
+1.84% | -10.60% |
| 05-01 | UBS Adjusts Price Target on Exponent to $75 From $85, Maintains Neutral Rating | MT |
| 04-30 | Exponent, Inc., Q1 2026 Earnings Call, Apr 30, 2026 |
Main competitors
| Consensus | Analysts' target price evolution (4 months) | Analysts' recommendations evolution (4 months) | Financial estimates divergence | Analysts' Target price divergence | Average Target P. | Objective/dr gap | Nbr of analysts | ||
|---|---|---|---|---|---|---|---|---|---|
 | 81.67 | +31.51% | 3 | ||||||
| 208.69 | +16.17% | 16 | ||||||
| 127.73 | +18.12% | 11 | ||||||
| 156.93 | +24.72% | 15 | ||||||
| 31.47 | +15.69% | 17 | ||||||
| 58.44 | +0.58% | 13 | ||||||
| 24.07 | +6.78% | 14 | ||||||
| 297.17 | +6.06% | 12 | ||||||
| 74.69 | +13.51% | 8 | ||||||
| 41 | +39.6% | 11 | ||||||
| - | 273.33 | +0.57% | 3 | |||||
| 153 | +46.78% | 2 | ||||||
| 41 | +50.18% | 8 | ||||||
| 77.23 | +48.18% | 13 | ||||||
| - | 50.27 | +11.88% | 3 | |||||
| 1,364 | +24.74% | 5 | ||||||
| - | 105 | +85.41% | 2 | |||||
| 3.106 | +38.28% | 12 | ||||||
| 52.43 | +17.55% | 7 | ||||||
| Average | 169.54 | +26.12% | 9 | ||||||
| Weighted average by Cap. | 164.18 | +19.16% | 13 |
- Stock Market
- Stocks
- EXPO Stock
- Sector Exponent, Inc.
- Sector consensus
Choose MarketScreener Select your edition
All financial news and data tailored to specific country editions
